Clinical trial
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced…
NCT00118300 · Case Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00118300 |
|---|---|
| Title | Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer |
| Official title | Phase I Study of Capecitabine (Xeloda) and Radiation Therapy in Patients With Locally Advanced Cervical and Pelvic Malignancies |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Vaginal Cancer |
| Intervention type | Drug, Radiation |
| Interventions | capecitabine, brachytherapy, radiation therapy |
| Enrollment | 0 |
| Start date | Apr 1, 2005 |
| First posted | Jul 11, 2005 |
| Last update posted | Jul 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: